These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 14962950

  • 21. Macrophage-expressed group IIA secretory phospholipase A2 increases atherosclerotic lesion formation in LDL receptor-deficient mice.
    Webb NR, Bostrom MA, Szilvassy SJ, van der Westhuyzen DR, Daugherty A, de Beer FC.
    Arterioscler Thromb Vasc Biol; 2003 Feb 01; 23(2):263-8. PubMed ID: 12588769
    [Abstract] [Full Text] [Related]

  • 22. Tagging SNP haplotype analysis of the secretory PLA2-V gene, PLA2G5, shows strong association with LDL and oxLDL levels, suggesting functional distinction from sPLA2-IIA: results from the UDACS study.
    Wootton PT, Arora NL, Drenos F, Thompson SR, Cooper JA, Stephens JW, Hurel SJ, Hurt-Camejo E, Wiklund O, Humphries SE, Talmud PJ.
    Hum Mol Genet; 2007 Jun 15; 16(12):1437-44. PubMed ID: 17545304
    [Abstract] [Full Text] [Related]

  • 23. Angiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A2-dependent lipid peroxidation.
    Luchtefeld M, Bandlow N, Tietge UJ, Grote K, Pfeilschifter J, Kaszkin M, Beck S, Drexler H, Schieffer B.
    Atherosclerosis; 2007 Sep 15; 194(1):62-70. PubMed ID: 17069818
    [Abstract] [Full Text] [Related]

  • 24. Proteolysis sensitizes LDL particles to phospholipolysis by secretory phospholipase A2 group V and secretory sphingomyelinase.
    Plihtari R, Hurt-Camejo E, Oörni K, Kovanen PT.
    J Lipid Res; 2010 Jul 15; 51(7):1801-9. PubMed ID: 20124257
    [Abstract] [Full Text] [Related]

  • 25. Hydrolysis of surfactant-associated phosphatidylcholine by mammalian secretory phospholipases A2.
    Hite RD, Seeds MC, Jacinto RB, Balasubramanian R, Waite M, Bass D.
    Am J Physiol; 1998 Oct 15; 275(4):L740-7. PubMed ID: 9755106
    [Abstract] [Full Text] [Related]

  • 26. Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2.
    Ivandic B, Castellani LW, Wang XP, Qiao JH, Mehrabian M, Navab M, Fogelman AM, Grass DS, Swanson ME, de Beer MC, de Beer F, Lusis AJ.
    Arterioscler Thromb Vasc Biol; 1999 May 15; 19(5):1284-90. PubMed ID: 10323781
    [Abstract] [Full Text] [Related]

  • 27. Human secretory phospholipase A2 mediates decreased plasma levels of HDL cholesterol and apoA-I in response to inflammation in human apoA-I transgenic mice.
    Tietge UJ, Maugeais C, Lund-Katz S, Grass D, deBeer FC, Rader DJ.
    Arterioscler Thromb Vasc Biol; 2002 Jul 01; 22(7):1213-8. PubMed ID: 12117740
    [Abstract] [Full Text] [Related]

  • 28. Phospholipase A2 and small, dense low-density lipoprotein.
    Hurt-Camejo E, Camejo G, Sartipy P.
    Curr Opin Lipidol; 2000 Oct 01; 11(5):465-71. PubMed ID: 11048889
    [Abstract] [Full Text] [Related]

  • 29. Lipoproteins are substrates for human secretory group IIA phospholipase A2: preferential hydrolysis of acute phase HDL.
    Pruzanski W, Stefanski E, de Beer FC, de Beer MC, Vadas P, Ravandi A, Kuksis A.
    J Lipid Res; 1998 Nov 01; 39(11):2150-60. PubMed ID: 9799801
    [Abstract] [Full Text] [Related]

  • 30. Atherogenic properties of LDL particles modified by human group X secreted phospholipase A2 on human endothelial cell function.
    Karabina SA, Brochériou I, Le Naour G, Agrapart M, Durand H, Gelb M, Lambeau G, Ninio E.
    FASEB J; 2006 Dec 01; 20(14):2547-9. PubMed ID: 17077289
    [Abstract] [Full Text] [Related]

  • 31. Mildly oxidized LDL induces expression of group IIa secretory phospholipase A(2) in human monocyte-derived macrophages.
    Anthonsen MW, Stengel D, Hourton D, Ninio E, Johansen B.
    Arterioscler Thromb Vasc Biol; 2000 May 01; 20(5):1276-82. PubMed ID: 10807743
    [Abstract] [Full Text] [Related]

  • 32. Minimal oxidation and storage of low density lipoproteins result in an increased susceptibility to phospholipid hydrolysis by phospholipase A2.
    Eckey R, Menschikowski M, Lattke P, Jaross W.
    Atherosclerosis; 1997 Jul 25; 132(2):165-76. PubMed ID: 9242962
    [Abstract] [Full Text] [Related]

  • 33. Secretory non-pancreatic phospholipase A2: influence on lipoprotein metabolism.
    de Beer FC, de Beer MC, van der Westhuyzen DR, Castellani LW, Lusis AJ, Swanson ME, Grass DS.
    J Lipid Res; 1997 Nov 25; 38(11):2232-9. PubMed ID: 9392421
    [Abstract] [Full Text] [Related]

  • 34. Hydrolysis of minor glycerophospholipids of plasma lipoproteins by human group IIA, V and X secretory phospholipases A2.
    Pruzanski W, Lambeau G, Lazdunski M, Cho W, Kopilov J, Kuksis A.
    Biochim Biophys Acta; 2007 Jan 25; 1771(1):5-19. PubMed ID: 17197234
    [Abstract] [Full Text] [Related]

  • 35. Secretory phospholipase A2 enzymes in atherogenesis.
    Webb NR.
    Curr Opin Lipidol; 2005 Jun 25; 16(3):341-4. PubMed ID: 15891396
    [Abstract] [Full Text] [Related]

  • 36. Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction.
    Arbibe L, Koumanov K, Vial D, Rougeot C, Faure G, Havet N, Longacre S, Vargaftig BB, Béréziat G, Voelker DR, Wolf C, Touqui L.
    J Clin Invest; 1998 Sep 15; 102(6):1152-60. PubMed ID: 9739049
    [Abstract] [Full Text] [Related]

  • 37. Tryptophan-containing mutant of human (group IIa) secreted phospholipase A2 has a dramatically increased ability to hydrolyze phosphatidylcholine vesicles and cell membranes.
    Baker SF, Othman R, Wilton DC.
    Biochemistry; 1998 Sep 22; 37(38):13203-11. PubMed ID: 9748327
    [Abstract] [Full Text] [Related]

  • 38. Analysis of secretory group II phospholipase A2 expression in human aortic tissue in dependence on the degree of atherosclerosis.
    Schiering A, Menschikowski M, Mueller E, Jaross W.
    Atherosclerosis; 1999 May 22; 144(1):73-8. PubMed ID: 10381280
    [Abstract] [Full Text] [Related]

  • 39. Exposure of macrophages to PLA2-modified lipoproteins leads to cellular lipid accumulations.
    Menschikowski M, Lattke P, Bergmann S, Jaross W.
    Anal Cell Pathol; 1995 Sep 22; 9(2):113-21. PubMed ID: 7492515
    [Abstract] [Full Text] [Related]

  • 40. Low-density lipoprotein from apolipoprotein E-deficient mice induces macrophage lipid accumulation in a CD36 and scavenger receptor class A-dependent manner.
    Zhao Z, de Beer MC, Cai L, Asmis R, de Beer FC, de Villiers WJ, van der Westhuyzen DR.
    Arterioscler Thromb Vasc Biol; 2005 Jan 22; 25(1):168-73. PubMed ID: 15514202
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.